Clinical Trial Update: Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating anti-TSLP AMG 157 in combination with antigen-specific immunotherapy for inducing tolerance in individuals with cat allergy; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cat Allergy
• Cat Hypersensitivity

Drugs mentioned

• AMG 157 (TSLP inhibitor)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cat Allergy, Cat Hypersensitivity | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-05-06